ng-nitroarginine methyl ester has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Counter, CM; Pershing, NL; Xu, M; Yang, CFJ | 1 |
| Katiyar, SK; Punathil, T | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Treatment with the nitric oxide synthase inhibitor L-NAME provides a survival advantage in a mouse model of Kras mutation-positive, non-small cell lung cancer.
Topics: Alleles; Animals; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease Models, Animal; Female; Genes, ras; Heterozygote; Humans; Lung Neoplasms; Male; Mice; Mutation; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Treatment Outcome | 2016 |
Inhibition of non-small cell lung cancer cell migration by grape seed proanthocyanidins is mediated through the inhibition of nitric oxide, guanylate cyclase, and ERK1/2.
Topics: Adenocarcinoma; Blotting, Western; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Cell Movement; Cell Proliferation; Cell Survival; Cyclic GMP; Enzyme Inhibitors; Fluorescent Antibody Technique; Grape Seed Extract; Guanylate Cyclase; Humans; Lung Neoplasms; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Plant Extracts; Proanthocyanidins; Quinoxalines; Receptors, Cell Surface; Signal Transduction; Tumor Cells, Cultured; Vitis | 2009 |